Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy. Oliva S, Molica S. Eur J Haematol 2025 Oct 21. doi: 10.1111/ejh.70047.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oliva S, Molica S. Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy. Eur J Haematol 2025 Oct 21. doi: 10.1111/ejh.70047.
PMID: 41116997